These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cost-effectiveness of dog rabies vaccination programs in East Africa. Borse RH; Atkins CY; Gambhir M; Undurraga EA; Blanton JD; Kahn EB; Dyer JL; Rupprecht CE; Meltzer MI PLoS Negl Trop Dis; 2018 May; 12(5):e0006490. PubMed ID: 29791440 [TBL] [Abstract][Full Text] [Related]
23. Healthcare demand in response to rabies elimination campaigns in Latin America. Yoder J; Younce E; Lankester F; Palmer GH PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007630. PubMed ID: 31557160 [TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of mass dog rabies vaccination strategies to reduce human health burden in Flores Island, Indonesia. Wera E; Mourits MCM; Hogeveen H Vaccine; 2017 Dec; 35(48 Pt B):6727-6736. PubMed ID: 29079100 [TBL] [Abstract][Full Text] [Related]
25. Quantifying the interconnectedness between poverty, health access, and rabies mortality. Taylor E; George K; Johnson E; Whitelegg H; Prada JM; Horton DL PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011204. PubMed ID: 37079553 [TBL] [Abstract][Full Text] [Related]
26. Integrating contact tracing and whole-genome sequencing to track the elimination of dog-mediated rabies: An observational and genomic study. Lushasi K; Brunker K; Rajeev M; Ferguson EA; Jaswant G; Baker LL; Biek R; Changalucha J; Cleaveland S; Czupryna A; Fooks AR; Govella NJ; Haydon DT; Johnson PCD; Kazwala R; Lembo T; Marston D; Masoud M; Maziku M; Mbunda E; Mchau G; Mohamed AZ; Mpolya E; Ngeleja C; Ng'habi K; Nonga H; Omar K; Rysava K; Sambo M; Sikana L; Steenson R; Hampson K Elife; 2023 May; 12():. PubMed ID: 37227428 [TBL] [Abstract][Full Text] [Related]
27. Rationale and support for a One Health program for canine vaccination as the most cost-effective means of controlling zoonotic rabies in endemic settings. Lavan RP; King AI; Sutton DJ; Tunceli K Vaccine; 2017 Mar; 35(13):1668-1674. PubMed ID: 28216188 [TBL] [Abstract][Full Text] [Related]
28. The urgency of resuming disrupted dog rabies vaccination campaigns: a modeling and cost-effectiveness analysis. Kunkel A; Jeon S; Joseph HC; Dilius P; Crowdis K; Meltzer MI; Wallace R Sci Rep; 2021 Jun; 11(1):12476. PubMed ID: 34127783 [TBL] [Abstract][Full Text] [Related]
29. Cost-Effectiveness of Mass Dog Vaccination Campaigns against Rabies in Flores Island, Indonesia. Wera E; Mourits MCM; Siko MM; Hogeveen H Transbound Emerg Dis; 2017 Dec; 64(6):1918-1928. PubMed ID: 27878980 [TBL] [Abstract][Full Text] [Related]
30. Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: a case study in Tanzania. Shim E; Hampson K; Cleaveland S; Galvani AP Vaccine; 2009 Nov; 27(51):7167-72. PubMed ID: 19925948 [TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of canine vaccination to prevent human rabies in rural Tanzania. Fitzpatrick MC; Hampson K; Cleaveland S; Mzimbiri I; Lankester F; Lembo T; Meyers LA; Paltiel AD; Galvani AP Ann Intern Med; 2014 Jan; 160(2):91-100. PubMed ID: 24592494 [TBL] [Abstract][Full Text] [Related]
32. Overview of rabies post-exposure prophylaxis access, procurement and distribution in selected countries in Asia and Africa, 2017-2018. Sreenivasan N; Li A; Shiferaw M; Tran CH; Wallace R; Blanton J; Knopf L; Abela-Ridder B; Hyde T; Vaccine; 2019 Oct; 37 Suppl 1(Suppl 1):A6-A13. PubMed ID: 31471150 [TBL] [Abstract][Full Text] [Related]
33. A review of the economics of the prevention and control of rabies. Part 1: Global impact and rabies in humans. Meltzer MI; Rupprecht CE Pharmacoeconomics; 1998 Oct; 14(4):365-83. PubMed ID: 10344905 [TBL] [Abstract][Full Text] [Related]
35. The role of vaccination in rabies prevention. Briggs DJ Curr Opin Virol; 2012 Jun; 2(3):309-14. PubMed ID: 22503445 [TBL] [Abstract][Full Text] [Related]
36. Should travellers to rabies-endemic countries be pre-exposure vaccinated? An assessment of post-exposure prophylaxis and pre-exposure prophylaxis given to Danes travelling to rabies-endemic countries 2000-12. Christiansen AH; Rodriguez AB; Nielsen J; Cowan SA J Travel Med; 2016 Apr; 23(4):. PubMed ID: 27147729 [TBL] [Abstract][Full Text] [Related]
37. Towards Canine Rabies Elimination in Cebu, Philippines: Assessment of Health Economic Data. Miranda LM; Miranda ME; Hatch B; Deray R; Shwiff S; Roces MC; Rupprecht CE Transbound Emerg Dis; 2017 Feb; 64(1):121-129. PubMed ID: 25885005 [TBL] [Abstract][Full Text] [Related]
38. Current and future tools for global canine rabies elimination. Franka R; Smith TG; Dyer JL; Wu X; Niezgoda M; Rupprecht CE Antiviral Res; 2013 Oct; 100(1):220-5. PubMed ID: 23871797 [TBL] [Abstract][Full Text] [Related]
39. Cost-Effectiveness Analysis of Integrated Bite Case Management and Sustained Dog Vaccination for Rabies Control. Taylor E; Prada JM; Del Rio Vilas V; Undurraga EA; Wallace R; Horton DL Am J Trop Med Hyg; 2023 Jul; 109(1):205-213. PubMed ID: 37188344 [TBL] [Abstract][Full Text] [Related]
40. One Health approach to cost-effective rabies control in India. Fitzpatrick MC; Shah HA; Pandey A; Bilinski AM; Kakkar M; Clark AD; Townsend JP; Abbas SS; Galvani AP Proc Natl Acad Sci U S A; 2016 Dec; 113(51):14574-14581. PubMed ID: 27994161 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]